DK1315709T3 - Aminoalkylbenzoyl-benzofuraner eller benzothiophener, fremgangsmåde til fremstilling deraf og sammensætninger indeholdende samme - Google Patents

Aminoalkylbenzoyl-benzofuraner eller benzothiophener, fremgangsmåde til fremstilling deraf og sammensætninger indeholdende samme

Info

Publication number
DK1315709T3
DK1315709T3 DK01963113.4T DK01963113T DK1315709T3 DK 1315709 T3 DK1315709 T3 DK 1315709T3 DK 01963113 T DK01963113 T DK 01963113T DK 1315709 T3 DK1315709 T3 DK 1315709T3
Authority
DK
Denmark
Prior art keywords
aminoalkylbenzoyl
benzothiophenes
benzofurans
processes
preparation
Prior art date
Application number
DK01963113.4T
Other languages
Danish (da)
English (en)
Inventor
Dino Nisato
Jean-Louis Assens
Frederique Cabanel-Haudricourt
Claude Bernhart
Patrick Gautier
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1315709T3 publication Critical patent/DK1315709T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
DK01963113.4T 2000-08-23 2001-08-21 Aminoalkylbenzoyl-benzofuraner eller benzothiophener, fremgangsmåde til fremstilling deraf og sammensætninger indeholdende samme DK1315709T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0010834A FR2813306B1 (fr) 2000-08-23 2000-08-23 Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
PCT/FR2001/002640 WO2002016339A1 (fr) 2000-08-23 2001-08-21 Aminoalkylbenzoyl-benzofuranes ou benzothiophenes, leur procede de preparation et les compositions les contenant

Publications (1)

Publication Number Publication Date
DK1315709T3 true DK1315709T3 (da) 2010-09-20

Family

ID=8853674

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01963113.4T DK1315709T3 (da) 2000-08-23 2001-08-21 Aminoalkylbenzoyl-benzofuraner eller benzothiophener, fremgangsmåde til fremstilling deraf og sammensætninger indeholdende samme

Country Status (36)

Country Link
US (1) US6949583B2 (US06949583-20050927-C00109.png)
EP (1) EP1315709B1 (US06949583-20050927-C00109.png)
JP (2) JP5081363B2 (US06949583-20050927-C00109.png)
KR (1) KR100911280B1 (US06949583-20050927-C00109.png)
CN (1) CN1246315C (US06949583-20050927-C00109.png)
AR (1) AR032892A1 (US06949583-20050927-C00109.png)
AT (1) ATE469138T1 (US06949583-20050927-C00109.png)
AU (2) AU2001284149B2 (US06949583-20050927-C00109.png)
BG (1) BG66240B1 (US06949583-20050927-C00109.png)
BR (1) BR0113425B1 (US06949583-20050927-C00109.png)
CA (1) CA2415847C (US06949583-20050927-C00109.png)
CY (1) CY1110738T1 (US06949583-20050927-C00109.png)
CZ (1) CZ304003B6 (US06949583-20050927-C00109.png)
DE (1) DE60142240D1 (US06949583-20050927-C00109.png)
DK (1) DK1315709T3 (US06949583-20050927-C00109.png)
EA (1) EA006237B1 (US06949583-20050927-C00109.png)
ES (1) ES2346291T3 (US06949583-20050927-C00109.png)
FR (1) FR2813306B1 (US06949583-20050927-C00109.png)
HK (1) HK1053113A1 (US06949583-20050927-C00109.png)
HU (1) HU229456B1 (US06949583-20050927-C00109.png)
IL (2) IL153632A0 (US06949583-20050927-C00109.png)
IS (1) IS2821B (US06949583-20050927-C00109.png)
MA (1) MA26943A1 (US06949583-20050927-C00109.png)
ME (2) ME00106B (US06949583-20050927-C00109.png)
MX (1) MXPA03001463A (US06949583-20050927-C00109.png)
NO (1) NO328138B1 (US06949583-20050927-C00109.png)
NZ (1) NZ523446A (US06949583-20050927-C00109.png)
OA (1) OA12359A (US06949583-20050927-C00109.png)
PL (1) PL219848B1 (US06949583-20050927-C00109.png)
PT (1) PT1315709E (US06949583-20050927-C00109.png)
RS (1) RS51603B (US06949583-20050927-C00109.png)
SI (1) SI1315709T1 (US06949583-20050927-C00109.png)
SK (1) SK288126B6 (US06949583-20050927-C00109.png)
TW (1) TWI290920B (US06949583-20050927-C00109.png)
WO (1) WO2002016339A1 (US06949583-20050927-C00109.png)
ZA (1) ZA200300744B (US06949583-20050927-C00109.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7401072B2 (en) * 2003-06-10 2008-07-15 Google Inc. Named URL entry
KR20140002810A (ko) * 2005-05-05 2014-01-08 사노피-아벤티스 유.에스. 엘엘씨 안정한 나노입자 제형
FR2893616B1 (fr) * 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
EP2308488A1 (en) 2009-10-09 2011-04-13 Sanofi-Aventis Use of celivarone for the preparation of a medicament for use in the prevention of implantable cardioverter defibrillator interventions or death
US20110207811A1 (en) * 2010-02-19 2011-08-25 Sanofi-Aventis Use of celivarone for reducing occurrences of cardiovascular hospitalization
FR2958290B1 (fr) 2010-03-30 2012-10-19 Sanofi Aventis Procede de preparation de derives de sulfonamido-benzofurane
HUP1000330A2 (en) 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
AU2011202542A1 (en) 2010-07-14 2012-02-02 Indian Institute Of Science Benzothiophene carboxamide compounds, composition and applications thereof
FR2963006B1 (fr) 2010-07-21 2013-03-15 Sanofi Aventis Procede de preparation de derives de nitro-benzofurane
FR2967067A1 (fr) 2010-11-10 2012-05-11 Sanofi Aventis Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation
HUP1100165A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Process for preparation of dronedarone by n-butylation
HUP1100167A2 (en) 2011-03-29 2012-11-28 Sanofi Sa Process for preparation of dronedarone by mesylation
CN102757444B (zh) * 2011-04-29 2016-02-10 南京信诺泰医药有限公司 具有一氧化氮供体性质的苯并呋喃类化合物
FR2983198B1 (fr) 2011-11-29 2013-11-15 Sanofi Sa Procede de preparation de derives de 5-amino-benzoyl-benzofurane
EP2617718A1 (en) 2012-01-20 2013-07-24 Sanofi Process for preparation of dronedarone by the use of dibutylaminopropanol reagent
WO2013121235A2 (en) 2012-02-13 2013-08-22 Sanofi Process for preparation of dronedarone by removal of hydroxyl group
WO2013121234A1 (en) 2012-02-14 2013-08-22 Sanofi Process for the preparation of dronedarone by oxidation of a sulphenyl group
WO2013124745A1 (en) 2012-02-22 2013-08-29 Sanofi Process for preparation of dronedarone by oxidation of a hydroxyl group
WO2013178337A1 (en) 2012-05-31 2013-12-05 Sanofi Process for preparation of dronedarone by grignard reaction
CN105315245B (zh) * 2014-06-16 2018-10-12 华润赛科药业有限责任公司 苯并呋喃类衍生物、其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248401A (en) * 1966-04-26 Diethylaminoe hoxybenzoyl benzofurans
GB1345872A (en) * 1970-09-03 1974-02-06 Wyeth John & Brother Ltd Amino-and acylamino-pyridine and hydropyridine derivatives
US4806663A (en) * 1987-04-06 1989-02-21 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4851554A (en) * 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4831054A (en) * 1988-04-18 1989-05-16 Taro Pharmaceuticals, Ltd. 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
AT391316B (de) * 1988-09-15 1990-09-25 Ebewe Arzneimittel Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5482949A (en) 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5364880A (en) * 1993-06-16 1994-11-15 Advanced Therapies, Inc. Compound for treatment of cardiac arrhythmia, synthesis, and methods of use
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5482950A (en) * 1993-10-15 1996-01-09 Eli Lilly And Company Methods for lowering serum cholesterol
US5523309A (en) * 1995-03-10 1996-06-04 Eli Lilly And Company Benzofuran pharmaceutical compounds
CA2217373A1 (en) * 1996-10-10 1998-04-10 Michael John Martin Benzo¬b|thiophene compounds, intermediates, formulations, and methods

Also Published As

Publication number Publication date
HUP0302968A3 (en) 2005-02-28
IL153632A (en) 2007-07-24
MA26943A1 (fr) 2004-12-20
AR032892A1 (es) 2003-12-03
EP1315709A1 (fr) 2003-06-04
CN1246315C (zh) 2006-03-22
SK288126B6 (sk) 2013-10-02
PL219848B1 (pl) 2015-07-31
CZ2003521A3 (cs) 2003-05-14
HUP0302968A2 (hu) 2003-12-29
FR2813306A1 (fr) 2002-03-01
SK2162003A3 (en) 2003-08-05
NO20030800L (no) 2003-04-23
BR0113425B1 (pt) 2014-02-25
CA2415847C (fr) 2011-09-27
ES2346291T3 (es) 2010-10-14
EA200300062A1 (ru) 2003-08-28
OA12359A (fr) 2006-05-16
TWI290920B (en) 2007-12-11
IS2821B (is) 2013-02-15
SI1315709T1 (sl) 2010-09-30
US20030225100A1 (en) 2003-12-04
NO328138B1 (no) 2009-12-14
FR2813306B1 (fr) 2005-10-21
PL362119A1 (en) 2004-10-18
CA2415847A1 (fr) 2002-02-28
JP5081363B2 (ja) 2012-11-28
DE60142240D1 (de) 2010-07-08
AU2001284149B2 (en) 2006-09-21
US6949583B2 (en) 2005-09-27
MEP23008A (en) 2010-06-10
BR0113425A (pt) 2003-07-15
IL153632A0 (en) 2003-07-06
ZA200300744B (en) 2004-02-05
CY1110738T1 (el) 2015-06-10
NO20030800D0 (no) 2003-02-20
NZ523446A (en) 2004-12-24
MXPA03001463A (es) 2004-05-04
KR20030023767A (ko) 2003-03-19
CN1471521A (zh) 2004-01-28
ATE469138T1 (de) 2010-06-15
PT1315709E (pt) 2010-07-29
EP1315709B1 (fr) 2010-05-26
KR100911280B1 (ko) 2009-08-11
JP2004506727A (ja) 2004-03-04
BG66240B1 (bg) 2012-08-31
JP5603849B2 (ja) 2014-10-08
RS51603B (sr) 2011-08-31
JP2012097100A (ja) 2012-05-24
EA006237B1 (ru) 2005-10-27
IS6677A (is) 2003-01-13
AU8414901A (en) 2002-03-04
BG107527A (bg) 2003-10-31
CZ304003B6 (cs) 2013-08-14
HK1053113A1 (en) 2003-10-10
ME00106B (me) 2010-10-10
HU229456B1 (en) 2013-12-30
WO2002016339A1 (fr) 2002-02-28
YU12903A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
DK1315709T3 (da) Aminoalkylbenzoyl-benzofuraner eller benzothiophener, fremgangsmåde til fremstilling deraf og sammensætninger indeholdende samme
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
NO20031500L (no) Brodekkepaneler, fremgangsmåte for fremstilling av samme og broer omfattende samme
NO20013242D0 (no) Benzopyraner og benzoksepiner, farmasöytiske preparater som omfatter dem, og fremgangsmåte for fremstilling av dem
IT1308628B1 (it) Composizioni fluoroelastomeriche.
ITTO20000779A0 (it) Composizioni farmaceutiche.
BR0015985B1 (pt) aplique, e, aeronave.
NO20016038L (no) Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
AU2578701A (en) Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
DK0791591T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
NO984444L (no) Benzothiofener, formuleringer som inneholder de samme og fremgangsmÕter
ITTO20000385A0 (it) Composizione pesticida.
BR9916537B1 (pt) composição de fragráncia, e, produto.
IT1321313B1 (it) Piastrella fratturabile per ottenere tozzetti o listelli, e relativometodo.
IL159614A0 (en) Benzofuran derivatives and pharmaceutical compositions containing the same
MXPA03005965A (es) Composicion farmaceutica que contiene citalopram.
DE29822443U1 (de) Absturzsicherung für Hubtische, Hebebühnen u.dgl.
DK1404663T3 (da) Eurotinoner og derivater deraf, fremgangsmåde til deres fremstilling og anvendelse heraf
DK1337528T3 (da) Benzothiophenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20011859D0 (no) Imidazoisokinolinforbindelser, deres sammensetninger og anvendelse
ES1042406Y (es) Expositor de piezas ceramicas, mejorado.
DK1345945T3 (da) Streptograminderivater, fremstilling heraf og sammensætninger, der indeholder dem